Showing results (171-180 of 193) with videos related to
Sort By:
Pageof 20
Archives of Surgery (Chicago, Ill. : 1960)|July 1, 1990
The importance of DNA flow cytometry in node-negative breast cancerD J Winchester, R B Duda, C Z August, et al.Journal of the National Cancer Institute|February 3, 1993
Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancerD C Allred, G M Clark, R Elledge, et al.Cancer Research|January 1, 1991
Variant human breast tumor estrogen receptor with constitutive transcriptional activityS A Fuqua, S D Fitzgerald, G C Chamness, et al.Anticancer Research|November 1, 1992
Expression of HER-2/neu oncoprotein in human breast cancer: a comparison of immunohistochemical and western blot techniquesR Molina, D R Ciocca, A K Tandon, et al.Surgery, Gynecology & Obstetrics|October 11, 1991
Estrogen receptor determination and long term survival of patients with carcinoma of the breastJ P Crowe, N H Gordon, C A Hubay, et al.Cancer|March 15, 1993
How to integrate steroid hormone receptor, flow cytometric, and other prognostic information in regard to primary breast cancerG M Clark, C R Wenger, S Beardslee, et al.Breast Cancer Research and Treatment|October 1, 1993
DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patientsC R Wenger, S Beardslee, M A Owens, et al.Proceedings of the National Academy of Sciences of the United States of America|October 1, 1984
Molecular cloning of a cDNA for the chicken progesterone receptor B antigenT Zarucki-Schulz, M S Kulomaa, D R Headon, et al.Human Pathology|September 1, 1992
Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancerD C Allred, G M Clark, R Molina, et al.Breast Cancer Research and Treatment|January 1, 1993
The ER-positive/PgR-negative breast cancer phenotype is not associated with mutations within the DNA binding domainS A Fuqua, D C Allred, R M Elledge, et al.Pageof 20